Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment – The Lancet

Commentary: COVID vaccination potential will not be achieved without increased production, affordable pricing, global availability – The Lancet

Commentaries on Twitter

NEW—#COVID19 vaccination potential will not be achieved without increased production, affordable pricing, global availability, & successful rollout. This Health Policy compares potential of 26 leading vaccines + vaccine confidence in 32 countries. Read https://t.co/QFeRDHutAi pic.twitter.com/rgknOgCVkg

— The Lancet (@TheLancet) February 12, 2021

The practical issues of #SARSCoV2 vaccines, a new and comprehensive review @TheLancet https://t.co/6sHsac44Ej best current summary of production, $, allocation, deployment, by @ojwouters @LSEHealthPolicy and colleagues pic.twitter.com/mMxOgkjyi0

— Eric Topol (@EricTopol) February 13, 2021